Table 1.
Patient characteristics according to treatment protocol
| Characteristics | Stent-implanted group | Medically treated group | p value |
|---|---|---|---|
| Patients | 34 (54.0) | 29 (46.0) | |
| Gender | 0.793 | ||
| Male | 20 (58.8) | 18 (62.1) | |
| Female | 14 (41.2) | 11 (37.9) | |
| Age, years | 67.88 ± 8.42 | 70.34 ± 6.99 | 0.484 |
| Vascular risk factors | |||
| Diabetes | 24 (70.6) | 17 (58.6) | 0.321 |
| Hypertension | 24 (70.6) | 20 (69.0) | 0.889 |
| Dyslipidemia | 4 (11.7) | 6 (20.6) | 0.677 |
| Cigarette smoking | 12 (35.2) | 15 (51.7) | 0.198 |
| Ischemic heart disease | 11 (32.4) | 14 (48.3) | 0.247 |
| Previous TIA or stroke | 4 (11.7) | 3 (10.3) | 0.289 |
| Presenting symptoms | 0.987 | ||
| Ischemic stroke | 20 (58.8) | 17 (58.6) | |
| TIA | 14 (41.2) | 12 (41.4) | |
| Lesion locations | 0.233 | ||
| ICA | 18 (52.9) | 11 (37.9) | |
| MCA | 16 (47.1) | 18 (62.1) | |
| Location of MCA occlusion | 0.356 | ||
| M1 segment | 9 (26.5) | 10 (34.5) | |
| M2 segment | 7 (20.6) | 8 (27.6) | |
| Location of ICA occlusion | |||
| Cavernous | 8 (23.5) | 8 (27.6) | |
| Petrous | 7 (20.6) | 2 (6.9) | |
| Petrocavernous | 3 (8.8) | 1 (3.4) | |
| Length of stenosis (≥7 vs. <7 mm) | 18 (52.9) | 12 (41.3) | 0.147 |
| Functional status (initial mRS score) | 0.867 | ||
| 2 | 4 (11.8) | 2 (6.9) | |
| 3 | 14 (42.2) | 12 (14.4) | |
| 4 | 6 (17.6) | 7 (24.1) | |
| 5 | 10 (29.4) | 8 (27.6) | |
| Initial NIHSS | 7.82 ± 3.05 | 7.59 ± 3.14 | 0.782 |
| Stenosis degree at presentation, % | 81.65 ± 1.26* | 77.09 ± 1.45* | 0.062 |
| Stenosis degree distribution | 0.055 | ||
| 70–80% | 20 (58.8) | 24 (82.8) | |
| 81–90% | 14 (41.2) | 5 (17.2) | |
| Follow-up duration, months | 15.18 ± 4.80 | 15.28 ± 4.76 | 0.802 |
Data are presented as means ± SD or numbers with percentages in parentheses. M1 = First segment of the MCA artery; M2 = second segment of the MCA artery.
*
Data are presented as means ± standard error.